Towards Healthcare
Healthcare Data Monetization Market to Reach USD 1923.5 Mn by 2034

Healthcare Data Monetization Market Trends 2025 North America Leads with 50% Share, Asia-Pacific Fastest Growing

Based on market forecasts, the global healthcare data monetization market, projected at USD 480 million in 2024, is expected to reach USD 1923.5 million by 2034, growing at a CAGR of 14.86% over the forecast period. The increasing adoption of advanced technologies and the growing need for personalized treatment drive the market. North America dominated due to the rising use of electronic health records and a robust healthcare infrastructure.

Category: Healthcare IT Insight Code: 6036 Format: PDF / PPT / Excel

Healthcare Data Monetization Market Size, Key Players and Segment Insights

The global healthcare data monetization market size is calculated at USD 480 million in 2024, grew to USD 551.4 million in 2025, and is projected to reach around USD 1923.5 million by 2034. The market is expanding at a CAGR of 14.86% between 2025 and 2034.

Healthcare Data Monetization Market Size 2024 to 2034

The healthcare data monetization market is primarily driven by the growing demand for personalized medicines to improve patient care. The increasing number of healthcare startups encourages companies to generate more revenue. Government organizations support the development and deployment of advanced technologies such as electronic health records (EHRs) in healthcare organizations. Prominent players collaborate to access healthcare data and provide enhanced patient care. Artificial intelligence (AI) helps manage and analyze complex data and suggest ways to monetize. The future looks promising, with technological advancements.

Key Takeaways

  • Healthcare data monetization market to crossed USD 480 million by 2024.
  • Market projected at USD 1923.5 million by 2034.
  • CAGR of 14.86% expected in between 2025 to 2034.
  • North America held a major revenue share of 50% in the market in 2024.
  • Asia-Pacific is expected to witness the fastest growth during the predicted timeframe.
  • By data type, the clinical data segment dominated the healthcare data monetization market with a share of 35% in 2024.
  • By data type, the patient-generated data segment is expected to account for the highest revenue share of the market in 2024.
  • By end-user, the pharmaceutical & biotechnology companies segment held the largest revenue share of 30% in the market in 2024.
  • By end-user, the research organizations & CROs segment is expected to grow at the fastest CAGR in the market during the forecast period.
  • By solution type, the data analytics platform segment led the market with a share of 40% in 2024.
  • By solution type, the data-as-a-service segment is expected to show the fastest growth over the forecast period.
  • By deployment mode, the cloud-based segment contributed the biggest revenue share of 55% in the healthcare data monetization market in 2024.
  • By deployment mode, the hybrid segment is expected to grow with the highest CAGR in the market during the studied years.
  • By data monetization model, the direct monetization segment accounted for the highest revenue share of 45% in the market in 2024.
  • By data monetization model, the indirect monetization segment is expected to witness the fastest growth in the market over the forecast period.

Key Indicators and Highlights

Table Scope
Market Size in 2025 USD 551.4 Million
Projected Market Size in 2034 USD 1923.5 Million
CAGR (2025 - 2034) 14.86%
Leading Region North America Share 50%
Market Segmentation By Data Type, By End-User, By Solution Type, By Deployment Mode, By Data Monetization Model, By Region
Top Key Players IBM Corporation, Optum (UnitedHealth Group), Oracle Corporation, Allscripts Healthcare Solutions, SAS Institute, Health Catalyst, MedeAnalytics, Truven Health Analytics (IBM Watson Health), IQVIA, Flatiron Health, Datavant, Humana Inc., Change Healthcare, Explorys (IBM Watson Health), Epic Systems Corporation, Philips Healthcare, Innovaccer, Symphony Health, Parexel International

Market Overview

The healthcare data monetization market refers to the practice of leveraging patient, provider, payer, and operational healthcare data to generate revenue streams, improve operational efficiency, and thereby enhance patient outcomes. This involves the collection, aggregation, analysis, and commercialization of healthcare-related datasets from electronic health records (EHRs), claims, diagnostic tests, clinical trials, wearable devices, and other digital health platforms.

Market participants offer services and technologies to extract actionable insights and monetize anonymized or de-identified data while maintaining regulatory compliance and ensuring patient privacy. The market growth is driven by the increasing adoption of digital health solutions, rising demand for real-world evidence in drug development, healthcare cost containment efforts, and advanced analytics capabilities.

Favorable Government Support: In July 2025, the U.S. government announced opening up app-based innovation and data sharing between patients and the wider healthcare system. The initiative, CMS Aligned Network, enables the sharing of patient medical records. This scheme also allows monetization of sensitive and personal health information.

Increasing Collaboration: In July 2025, Datavault AI, Inc. and IBM announced expanded commercialization of DataScore and DataValue. The integration of AI agents and expertise helps customers streamline their enterprise financial modeling, risk assessment, and pricing strategies.

What is the Role of AI in the Healthcare Data Monetization Market?

AI plays an indispensable role in transforming healthcare data monetization by storing, managing, and analyzing vast amounts of patient data efficiently. It overcomes several challenges of conventional methods, such as organizing decentralized and fragmented data. AI and machine learning (ML) algorithms enable performance predictions, financial predictions, and cost-benefit analysis, allowing providers to make informed decisions. Generative AI (gen AI) can reason and make autonomous decisions, enabling the data-driven future of the enterprise. It can unlock structured data and turn raw data into actionable insights.

Market Dynamics

Driver

Increasing Competition

The major growth factor for the healthcare data monetization market is the increasing competition among healthcare organizations. The rising number of healthcare startups and venture capital investments enhances competition among healthcare organizations. In the first half of 2025, the total U.S. healthcare venture capital investment was around $3 billion, according to a report by Silicon Valley Bank.This enables them to expand their product portfolio and provide personalized services. In response to increasing competition, healthcare organizations adopt advanced technologies to manage and analyze huge amounts of patient data.

Restraint

Fragmented Data

Healthcare data monetization becomes difficult due to a fragmented network of healthcare providers, payers, and patients, hindering data exchange. This limits the ability to create comprehensive patient views and derive valuable insights.

Opportunity

What is the Future of the Healthcare Data Monetization Market?

The market future is promising, driven by the increasing use of innovative technologies, such as blockchain technology and the Internet of Things (IoT) devices. Blockchain technology provides a decentralized infrastructure for managing healthcare data. It ensures transparency and security, allowing data owners to control access while maintaining data integrity. Blockchain-based smart contracts facilitate automated transactions, reducing dependency on intermediaries. This also enhances efficiency in data sharing agreements. Additionally, the data collection becomes easier with the use of IoT devices. IoT devices benefit healthcare companies, insurance firms and healthcare providers.

Segmental Insights

How the Clinical Data Segment Dominated the Healthcare Data Monetization Market?

By data type, the clinical data segment held a dominant presence in the market in 2024. This is due to the need for high-quality patient care and the development of novel diagnostics and therapeutics. Clinical data is essential as it enables healthcare professionals to study patient behavior, allowing them to develop evidence-based medicines. It also provides insights into treatment effectiveness and potential risks, leading to better patient care. The increasing need for personalized medicines due to rapidly changing demographics potentiates the demand for clinical data.

The EHR/EMR data sub-segment held the largest revenue share. Many hospitals prefer adopting EHRs or electronic medical records (EMRs) to generate clinical data, allowing providers to provide personalized care. EHRs and EMRs also enable data sharing among different healthcare organizations.

By data type, the patient-generated data segment is expected to grow at the fastest CAGR in the market during the forecast period. Patient-generated data is a vital source for remote monitoring and offers a more complete picture of a patient. Advancements in technology, such as wearable medical devices and mobile apps, streamline the generation of patient data. Patient-generated data allows professionals to provide personalized care, improving health outcomes. Integrating patient-generated data into clinical care holds potential for the successful diagnosis and improved management of health conditions.

The wearables & remote monitoring sub-segment is expected to expand rapidly. The demand for wearable devices, such as smartwatches, rings, and fitness trackers, is increasing, driven by advances in biosensors and enhanced awareness of a healthy lifestyle. These devices aid in monitoring patient vital signs and increase patient-provider collaboration.

Which End-User Segment Dominated the Healthcare Data Monetization Market?

By end-user, the pharmaceutical & biotechnology companies segment contributed the biggest revenue share of the market in 2024. The segmental growth is attributed to the increasing need to expand the product portfolio. Pharmaceutical & biotech companies have suitable capital investments to adopt advanced technologies for research purposes. This enables them to develop novel healthcare products. They leverage patient information obtained from hospitals and clinics to generate revenue and strengthen their market position.

By end-user, the research organizations & CROs segment is expected to grow with the highest CAGR in the market during the studied years. Research organizations & CROs purchase healthcare data from hospitals, clinics, and other healthcare organizations. They also play a vital role in research activities and clinical trials, thereby generating healthcare data. They provide the relevant expertise and infrastructure to conduct clinical trials efficiently and effectively.

Why Did the Data Analytics Platform Segment Dominate the Healthcare Data Monetization Market?

By solution type, the data analytics platform segment accounted for the highest revenue share of the market in 2024. This segment dominated because the data analytics platform simplifies the collection, processing, and analysis of huge healthcare data and gathers insights by integrating multiple data sources. It can also enable real-time data processing, allowing users to make informed decisions based on clinical data. It reduces manual errors in storing and analyzing data, as well as shares results across teams and shareholders.

The predictive analytics sub-segment held the largest revenue share. Predictive analytics uses historical and current patient data to predict future outcomes. This helps providers to deliver personalized care and detect potential adverse effects before providing treatment, improving the quality of care and saving costs.

By solution type, the data-as-a-service segment is expected to witness the fastest growth in the market over the forecast period. Certain organizations provide data on demand to various healthcare organizations irrespective of their location or infrastructure. Data-as-a-Service (DaaS) operates on a cloud platform, consolidating and organizing healthcare data in one place. The numerous benefits of DaaS include reduced risk, improved innovation, and lower costs.

The real-world evidence solutions sub-segment is expected to expand rapidly. Real-world evidence (RWE) solutions are commonly used to monitor and evaluate the postmarket safety of licensed drugs, supporting regulatory decisions. It is clinical evidence on a medical product’s safety and efficacy.

Which Deployment Mode Segment Led the Healthcare Data Monetization Market?

By deployment mode, the cloud-based segment led the global market in 2024. This is due to the ability of cloud-based solutions to store large amounts of healthcare data. Professionals can access data from anywhere and at any time. Cloud-based solutions operate on the internet, eliminating the need for a specialized infrastructure. They enable healthcare organizations to securely store, manage, and analyze their data for unlocking new paradigms.

By deployment mode, the hybrid segment is expected to show the fastest growth over the forecast period. Hybrid solutions leveraging on-premises and cloud-based solutions offer the benefits of both. Healthcare professionals can access healthcare data online and offline, thereby maintaining data privacy and security. Hybrid solutions favor scalability and cost-effectiveness. They also maintain sensitive data and enable data analytics and sharing.

What Made Direct Monetization the Dominant Segment in the Healthcare Data Monetization Market?

By data monetization model, the direct monetization segment registered its dominance over the global market in 2024. This segment dominated because direct monetization refers to providing healthcare data to third parties, such as pharmaceutical companies, research institutions, and other healthcare organizations. Direct monetization reduces the risk of data leakage, maintaining patient privacy. It is the most common form of data sharing, providing accurate and precise insights into patient health and medical products.

The selling anonymized data sub-segment held the largest revenue. The growing need to protect patient privacy facilitates the de-identification and anonymization of healthcare data. Anonymizing healthcare data involves making the data untraceable to a specific individual by removing any information used to re-identify the person.

By data monetization model, the indirect monetization segment is expected to account for the highest revenue share of the market in 2024. Indirect monetization is achieved by enhancing patient outcomes, driving operational efficiency, and strategic partnerships among healthcare organizations. Healthcare professionals take several measures to achieve these, thereby generating revenue. This builds trust among patients and clients.

The strategic partnerships sub-segment is expected to expand rapidly. The increasing collaborations and merger & acquisition activities among healthcare companies foster the segment’s growth. This enables them to access their data and medical products, thereby ultimately generating revenue.

Regional Analysis

Healthcare Data Monetization Market Share, By Region, 2024 (%)

Which Factors Govern the Healthcare Data Monetization Market in North America?

North America dominated the market share 50% in 2024. The presence of key players, a robust healthcare infrastructure, and favorable government support are the major growth factors of the market in North America. Government organizations provide incentives and launch initiatives to support healthcare data. The rising adoption of EHRs in healthcare organizations augments market growth. The increasing number of clinical trials in the region potentiates the chance of revenue generation.

U.S. Market Trends

It is estimated that over 96% of the hospitals in the U.S. have adopted EHRs. Key players, such as IBM Corporation, Oracle Corporation, and Wipro, are the major contributors to the market in the U.S. As of August 2025, 184,642 clinical trials were registered on the clinicaltrials.gov website in the U.S.

Canada Market Trends

The Canadian government launched the “Working Together to Improve Health Care for Canadians” plan to improve health services in Canada. It aims to provide $200 million over 10 years, including $25 million in targeted bilateral funding for provinces and territories. The plan includes how governments can improve the collection, sharing, and storing of health data.

Venture Capital Investments Promote Asia-Pacific

Asia-Pacific is expected to grow at the fastest CAGR in the healthcare data monetization market during the forecast period. The burgeoning healthcare sector and increasing investments by government and private organizations boost the market. The region is expanding due to the rising number of healthcare startups and the need for enhanced patient care. The increasing awareness of the value of patient data for various applications favors market growth.

China Market Trends

China is home to more than 2,618 health tech startups, of which 1,113 are funded. The healthcare sector collectively raised about $25 billion in the last decade. As of August 2025, the total funding was $313 million. In 2024, 4 acquisitions happened in the healthcare sector. There are more than 3,000 internet hospitals in China, benefitting over 26 million people.

India Market Trends

The Department for Promotion of Industry and Internal Trade (DPIIT) reported that there are over 1,000 startups in the healthcare sector in India. India raised the highest venture capital investment in the APAC region. In Q2 2025, PB Healthcare raised $218 million to focus on developing a tech-enabled health delivery platform, making it India’s largest VC investment of Q2 2025.

Favorable Government Support to Drive Europe

Europe is expected to grow at a considerable CAGR in the healthcare data monetization market in the upcoming period. The growing demand for personalized medicines and favorable government support bolster market growth. Government agencies encourage healthcare organizations to adopt digitalized solutions, improving patient care. The rising adoption of advanced technologies in healthcare organizations and the presence of major players propel market growth. The increasing collaborations and mergers & acquisitions among key players help access advanced data and technologies.

UK Market Trends

The UK government announced an action plan to accelerate the discovery of life-saving drugs. The government and the Wellcome Trust will invest up to £600 million to create a new health data research service. It also aims to fast-track to accelerate the development of medicines and therapies of the future.

Top Companies in the Healthcare Data Monetization Market

Healthcare Data Monetization Market Companies

  • IBM Corporation
  • Optum (UnitedHealth Group)
  • Oracle Corporation
  • Allscripts Healthcare Solutions
  • SAS Institute
  • Health Catalyst
  • MedeAnalytics
  • Truven Health Analytics (IBM Watson Health)
  • IQVIA
  • Flatiron Health
  • Datavant
  • Humana Inc.
  • Change Healthcare
  • Explorys (IBM Watson Health)
  • Epic Systems Corporation
  • Philips Healthcare
  • Innovaccer
  • Symphony Health
  • Parexel International

Latest Announcement by Industry Leaders

Mitesh Rao, CEO of OMNY Health, commented that life science organizations and providers struggle with time and budget constraints that hinder their ability to learn from their data. The company’s AI-driven platforms can streamline this process by partnering with AI developers to leverage data and tools, thereby accelerating breakthrough therapies and monitoring new therapies for safety signals.

Recent Developments in the Healthcare Data Monetization Market

  • In January 2025, Selfii announced the launch of TripleBlind Exchange, a first-of-its-kind marketplace to enable secure access to protected health information (PHI). The platform allows application developers to access data, train LLMs, and deploy models. It also enables companies to build data-driven applications and engage in data monetization.
  • In October 2024, datma launched datma.FED, an innovative two-sided marketplace, is to revolutionize the sharing, accessibility, and monetization of healthcare data. The platform connects health systems and reference labs with pharmaceutical companies and research organizations.

Segments Covered in the Report

By Data Type

  • Clinical Data
    • EHR/EMR Data
    • Lab & Diagnostic Data
    • Imaging Data
    • Clinical Trial Data
    • Others
  • Patient-Generated Data
    • Wearables & Remote Monitoring
    • Mobile Health Apps Data
    • Patient Surveys & Feedback
    • Others
  • Claims Data
    • Insurance Claims
    • Pharmacy Claims
    • Others
    • Genomic & Molecular Data
    • Sequencing Data
    • Biomarker Data
    • Others
  • Operational Data
    • Hospital Operations
    • Supply Chain Data
    • Resource Utilization Data
    • Others

By End-User

  • Pharmaceutical & Biotech Companies
  • Research Organizations & CROs
  • Healthcare Providers
  • Payers & Insurance Companies
  • Government & Public Health Agencies
  • Others

By Solution Type

  • Data Analytics Platform
    • Predictive Analytics
    • Descriptive Analytics
    • Prescriptive Analytics
    • Others
  • Data-as-a-Service (DaaS)
    • Aggregated Data Services
    • On-Demand Analytics
    • Real-World Evidence Solutions
    • Others
  • Consulting & Advisory Services
    • Data Security & Compliance Services
    • Others

By Deployment Mode

  • On-premises
  • Cloud-based
  • Hybrid

By Data Monetization Model

  • Direct Monetization
  • Selling Anonymized Data
  • Data Licensing & Subscriptions
  • Indirect Monetization
  • Strategic Partnerships
  • Enhanced Patient Outcomes
  • Operational Efficiency
  • Others

By Region 

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
  • Last Updated: 22 August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar, with over 14 years of experience in consumer goods, leads research at Towards Consumer Goods, ensuring precise, actionable insights on trends, consumer preferences, and sustainable packaging for businesses.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

The healthcare data monetization market in 2025 is valued at USD 551.4 million and is projected to climb to USD 1923.5 million by 2034, with a CAGR of 14.86% over the forecast period.

North America is leading the healthcare data monetization market due to a robust healthcare infrastructure, the increasing adoption of EHRs, and the presence of key players.

The healthcare data monetization market includes 6 segments by data type, by end-user, by solution type, by deployment mode, by data monetization model, and by region.

Some key players include IBM Corporation, IQVIA, and Parexel International.

Data monetization involves significant legal risks, primarily due to stringent regulations like GDPR and CCPA. Non-compliance may lead to hefty penalties and reputational harm.

Food and Drug Administration, clinicaltrials.gov, Government of Canada, India Brand Equity Foundation, GOV.UK